CA1006159A - D-6-methyl 2,8-disubstituted ergolines - Google Patents

D-6-methyl 2,8-disubstituted ergolines

Info

Publication number
CA1006159A
CA1006159A CA177,021A CA177021A CA1006159A CA 1006159 A CA1006159 A CA 1006159A CA 177021 A CA177021 A CA 177021A CA 1006159 A CA1006159 A CA 1006159A
Authority
CA
Canada
Prior art keywords
methyl
ergolines
disubstituted
disubstituted ergolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA177,021A
Other languages
English (en)
Other versions
CA177021S (en
Inventor
Nicholas J. Bach
James A. Clemens
Edmund C. Kornfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1006159A publication Critical patent/CA1006159A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA177,021A 1972-07-21 1973-07-20 D-6-methyl 2,8-disubstituted ergolines Expired CA1006159A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27390272A 1972-07-21 1972-07-21

Publications (1)

Publication Number Publication Date
CA1006159A true CA1006159A (en) 1977-03-01

Family

ID=23045910

Family Applications (1)

Application Number Title Priority Date Filing Date
CA177,021A Expired CA1006159A (en) 1972-07-21 1973-07-20 D-6-methyl 2,8-disubstituted ergolines

Country Status (24)

Country Link
JP (2) JPS576431B2 (xx)
AR (3) AR206772A1 (xx)
AT (1) AT331425B (xx)
BE (1) BE802531A (xx)
BG (3) BG21411A3 (xx)
CA (1) CA1006159A (xx)
CH (5) CH581135A5 (xx)
CS (1) CS208164B2 (xx)
DD (1) DD107690A5 (xx)
DE (2) DE2335750C3 (xx)
DK (1) DK140986B (xx)
ES (5) ES417078A1 (xx)
FR (1) FR2193606B1 (xx)
GB (1) GB1423065A (xx)
HU (1) HU167274B (xx)
IE (1) IE37936B1 (xx)
IL (3) IL42730A (xx)
NL (1) NL7309969A (xx)
PH (1) PH11229A (xx)
RO (2) RO71305A (xx)
SE (3) SE393111B (xx)
SU (3) SU645581A3 (xx)
YU (1) YU36953B (xx)
ZA (1) ZA734627B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
JPH0596382U (ja) * 1992-05-28 1993-12-27 イビデン株式会社 ドアユニット

Also Published As

Publication number Publication date
IL48288A (en) 1976-06-30
IL48288A0 (en) 1975-12-31
SE7611466L (sv) 1976-10-15
ES417078A1 (es) 1976-05-01
DK140986C (xx) 1980-07-21
GB1423065A (en) 1976-01-28
AT331425B (de) 1976-08-25
PH11229A (en) 1977-10-28
JPS4985099A (xx) 1974-08-15
IE37936B1 (en) 1977-11-23
CH580626A5 (xx) 1976-10-15
AR206887A1 (es) 1976-08-31
IL42730A (en) 1976-06-30
SU584780A3 (ru) 1977-12-15
SE393111B (sv) 1977-05-02
DE2335750B2 (de) 1978-02-23
JPS5781487A (en) 1982-05-21
DE2365974A1 (de) 1977-03-24
DE2335750C3 (de) 1978-10-19
DD107690A5 (xx) 1974-08-12
JPS576431B2 (xx) 1982-02-04
SE410459B (sv) 1979-10-15
BG22400A3 (xx) 1977-02-20
CH581135A5 (xx) 1976-10-29
CH578563A5 (xx) 1976-08-13
YU194573A (en) 1982-06-18
BG21411A3 (xx) 1976-05-20
BG21410A3 (xx) 1976-05-20
ES442886A1 (es) 1977-04-16
ES446789A1 (es) 1977-06-01
CH580625A5 (xx) 1976-10-15
ATA643473A (de) 1975-11-15
NL7309969A (xx) 1974-01-23
RO71305A (ro) 1982-03-24
AR210072A1 (es) 1977-06-30
AU5792673A (en) 1975-01-16
IE37936L (en) 1974-01-21
DK140986B (da) 1979-12-17
IL42730A0 (en) 1973-10-25
FR2193606B1 (xx) 1977-07-15
CS208164B2 (en) 1981-08-31
CH578564A5 (xx) 1976-08-13
BE802531A (fr) 1974-01-21
SU575029A3 (ru) 1977-09-30
ES442885A1 (es) 1977-04-16
FR2193606A1 (xx) 1974-02-22
YU36953B (en) 1984-08-31
SE410603B (sv) 1979-10-22
JPS5813541B2 (ja) 1983-03-14
HU167274B (xx) 1975-09-27
RO63792A (fr) 1978-12-15
SE7611467L (sv) 1976-10-15
ZA734627B (en) 1974-06-26
AR206772A1 (es) 1976-08-23
SU645581A3 (ru) 1979-01-30
ES442887A1 (es) 1977-05-16
DE2335750A1 (de) 1974-02-14

Similar Documents

Publication Publication Date Title
KE2670A (en) 1,2,3,-thiadiazole derivatives
CA1012534A (en) 2,6-diaminonebularine derivatives
CA966134A (en) 1,8-naphthyridine compounds
CA1006159A (en) D-6-methyl 2,8-disubstituted ergolines
GB1406961A (en) 2,4,7-trioxopteridine derivatives
CA988522A (en) 1,8-naphthyridine compounds
CA993452A (en) 2,6-dihalo-4-cyanophenoxy-acetonitriles
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
AU477308B2 (en) 10-alkoxy-4h-benzo [4,5] cyclogepta [1,2-b] thiophen-4-ones
HK15179A (en) 2,6-diaminoneburlarine derivatives
CA1020953A (en) 2,2,3-endo-trimethyl-7-anti-amino-norbornanes
AU481948B2 (en) D-6-methyl 2, 8-disubstituted ergolines
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
AU472337B2 (en) 11, 12-secoprostaglandins
CA999595A (en) 3,5-dialkyl-4-hydroxybenzyl-oxiranes and -thiiranes
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
AU474523B2 (en) Substituted 9,10-dihydroanthracenes
CA986936A (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
CA990280A (en) 5,6-trans-25-hydroxycholecalciferol
CA987669A (en) 10,11-anhydroerythromycins
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
CA900967A (en) 6,7-disubstituted oestratrienes
CA959054A (en) 2,3-benzoxazepine derivatives
CA900975A (en) 8,5 - amino - substituted-tetrahydrohalo-sulfamyl-quinazolinones
CA897172A (en) 3,4-dihydronaphthalenoneoxy-2-hydroxypropylamines